Associated Papers
Identification and prioritization of gene sets associated with schizophrenia risk by network analysis.
Yu M et al.
Psychopharmacology, 2025
Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders.
Bach S et al.
Scientific Reports, 2020
33335218 (PubMed )
Supplement: 41598_2020_79268_MOESM1_ESM.xlsx › Table_S4
Detection of Rare Methyl-CpG Binding Protein 2 Gene Missense Mutations in Patients With Schizophrenia.
Chen CH et al.
Frontiers in Genetics, 2020
MeCP2 AT-Hook1 mutations in patients with intellectual disability and/or schizophrenia disrupt DNA binding and chromatin compaction in vitro.
Sheikh TI et al.
Human Mutation, 2018
Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families.
Harripaul R et al.
Molecular Psychiatry, 2018
Asperger syndrome and early-onset schizophrenia associated with a novel MECP2 deleterious missense variant.
Curie A et al.
Psychiatric Genetics, 2017
De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability.
McCarthy SE et al.
Molecular Psychiatry, 2014
Select a paper to view details